Form 4: Director Andre Fernandez Acquires Cardlytics Stock

Director Andre Fernandez reported the acquisition of 11,000 restricted stock units of Cardlytics, Inc. (CDLX) on May 20, 2026.

Summary

• Director Andre J. Fernandez acquired 11,000 shares of Cardlytics, Inc. common stock through the vesting of restricted stock units (RSUs) on May 20, 2026.
• These RSUs were granted with a purchase price of $0.
• Following this transaction, Mr. Fernandez beneficially owns 26,310 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard insider transaction related to equity compensation rather than a strategic business development or financial performance update.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The acquisition was made through the vesting of RSUs, indicating a performance-based compensation structure.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to a change in beneficial ownership.

Industry Context

StockSavvy.ai notes that insider transactions, such as this acquisition by a director, are closely watched by the market as potential indicators of management's view on the company's valuation and future performance within the digital advertising and financial technology sectors.

Stakeholder Impact

• Shareholders: May interpret the director's acquisition of stock as a positive signal of confidence in the company's future.

Key Dates

Keywords

Cardlytics, CDLX, Form 4, SEC Filing, Insider Trading, Stock Acquisition, Restricted Stock Units, Director, Beneficial Ownership